DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20204419

Patients with a previous stroke attack who suffer from blood pressure control or regulation in Saudi Arabia

Khaled M. Hassan, Abdulwahab A. Alqahtani, Mohammed W. Alotaibi, Abdulaziz A. Alahmari, Salwa M. Alanazi, Ghadah O. Al-Hussain, Mesedah A. Alnahdi, Faisal A. Alharbi, Ahmed A. Alshehri, Ziyad A. Aloraini, Sulaiman H. Almutairi, Bara A. Baw, Bader A. Alamer, Khaled M. Alsassiri, Maha A. Alfaraj, Abdulmohsen M. Alotaibi

Abstract


This study aims to discuss the blood pressure (BP) control with patients who suffer from a previous stroke or transient ischemic attack (TIA) in Saudi Arabia, to discuss the risk factors and to examine antihypertensive medication-dosing. The most recent office-based BP reading was compared with the BP <140/90 mmHg objective of the National Institute for Health and Care Excellence (NICE) (NG136) and European Society of Hypertension or European Society of Cardiology (ESH/ESC 2013) study participants. By benchmarking prescription doses for each drug with the World Health Organization-defined daily dosing (WHO-DDD) guidelines, optimal anti-hypertensive medication dosing was calculated. In 10 procedures, we found 328 patients with a prior stroke or TIA. When assessed against the ESH/ESC and NICE guidelines (63.1 percent, n=207), blood pressure was controlled in nearly two-thirds of patients. Of those with BP 140/90 (n=116), just under half (n=44, 47.3 percent) were sufficiently dosed relative to the WHO-DDD guidelines in all anti-hypertensive medicines. To conclude, in at least one-third of patients with a prior stroke or TIA, blood pressure regulation remains sub-optimal. Half of these patients were able to respond to an elevation of the anti-hypertensive dose. Further analysis is needed to see how best to control blood pressure in primary care patients with a previous stroke or TIA, since the majority of hypertension consultations take place in this setting.


Keywords


Blood pressure control, Previous stroke, Transient ischemic attack, Primary care, Saudi Arabia

Full Text:

PDF

References


Webb A, Heldner M, Aguiar de Sousa D, Sandset E, Randall G, Bejot Y, et al. Availability of secondary prevention services after stroke in Europe: an ESO/SAFE survey of national scientific societies and stroke experts. Eur Stroke J. 2019;4(2):110-8.

Norrving B, Barrick J, Davalos A, Dichgans M, Cordonnier C, Guekht A, et al. Action plan for stroke in Europe 2018-2030. Eur Stroke J. 2018;3(4):309-36.

Amarenco P, Lavallée PC, Monteiro Tavares L, Labreuche J, Albers GW, Abboud H, et al. Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med. 2018;378(23):2182-90.

O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761-75.

Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.

Zhou B, Danaei G, Stevens GA, Bixby H, Taddei C, Carrillo-Larco RM, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394(10199):639-51.

Hameed MA, Dasgupta I. Medication adherence and treatment-resistant hypertension: a review. Drugs Context. 2019;8:212560.

Ogedegbe G. Barriers to optimal hypertension control. J Clin Hypertens. 2008;10(8):644-6.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104.

Hayes P, Casey M, Glynn LG, Molloy GJ, Durand H, O'Brien E, et al. Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care. Br J Gen Pract. 2018;68(671):e394-400.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159.

NICE. Hypertension in adults: diagnosis and management: NICE guideline [NG136] National Institute for Health and Care Excellence; 2019. Available at: https://www.nice.org.uk/guidance/ ng136. Accessed on 20 August, 2020.

Health Service Executive. Medical card application process 2018. Available from: https://www2.hse.ie/ services/medical-cards/medical-card-application-process/how-much-you-can-earn-and-still-qualify-for-a-medical-card.html. Accessed on 20 August 2020.

Health Service Executive. Primary Care Reimbursement Service. Statistical Analysis of Claims and Payments 2018. Dublin: Health Service Executive, Primary Care Reimbursement Service; 2018. Accessed on 20 August 2020.

World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision. 2004. Accessed on

World Organization of National Colleges A. Academic Associations of General Practitioners/Family Physicians, ICPC-2-R. International Classification of Primary Care. Revised Second Edition. USA: Oxford University Press. 2005. Accessed on 20 August, 2020.

Egan BM, Zhao Y, Li J, Brzezinski WA, Todoran TM, Brook RD, et al. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Hypertension. 2013;62(4):691-7.

IBM. IBM SPSS Statistics for Windows. Version 26 ed. Aramonk: IBM Corp. 2018. Available at: http://www-03.ibm.com/press/us/en/pressrelease/ 27936. Accessed on 31 August 2014.

Pedersen RA, Petursson H, Hetlevik I. Stroke follow-up in primary care: a prospective cohort study on guideline adherence. BMC Fam Pract. 2018;19(1):179.

Smith S, Horgan F, Sexton E, Cowman S, Hickey A, Kelly P, et al. The cost of stroke and transient ischaemic attack in Ireland: a prevalence-based estimate. Age Ageing. 2012;41(3):332-8.

Smith S, Horgan F, Sexton E, Wiley M. Cost of Stroke in Ireland. Estimating the annual economic cost of stroke and transient ischaemic attack (TIA) in Ireland. Dublin: Economic and Social Research Institute (ESRI) and the Royal College of Surgeons in Ireland (RCSI) for the Irish Heart Foundation. 2010.

Xu X-M, Vestesson E, Paley L, Desikan A, Wonderling D, Hoffman A, et al. The economic burden of stroke care in England, Wales and Northern Ireland: using a national stroke register to estimate and report patient-level health economic outcomes in stroke. Eur Stroke J. 2018;3(1):82-91.

SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103-16.

Ministry of Health. Annual statistical book. Riyadh: Ministry of Health; (2017). Available at: https:// www.moh.gov.sa/en/Ministry/Statistics/book/Documents/ANNUAL-STATISTICAL-BOOK-1438H.pdf. Accessed on 20 August 2020.

McCormack T, Boffa RJ, Jones NR, Carville S, McManus RJ. The 2018 ESC/ESH hypertension guideline and the 2019 NICE hypertension guideline, how and why they differ. Eur Heart J. 2019;40(42):3456-8.

Group SPSS, Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382(9891):507-15.

Gil-Guillen V, Orozco-Beltran D, Carratala-Munuera C, Marquez-Contreras E, Durazo-Arvizu R, Cooper R, et al. Clinical inertia in poorly controlled elderly hypertensive patients: a cross-sectional study in Spanish physicians to ascertain reasons for not intensifying treatment. Am J Cardiovasc Drugs. 2013;13(3):213-9.

Yang W-Y, Melgarejo JD, Thijs L, Zhang Z-Y, Boggia J, Wei F-F, et al. Association of Office and Ambulatory Blood Pressure with Mortality and cardiovascular Outcomes Association of office and ambulatory blood pressure with mortality and CV Outcomes. JAMA. 2019;322(5):409-20.

McElwaine P, McCormack J, Harbison J. National Stroke Audit 2015. Report; 2015. Accessed on 20 August, 2020.

Executive HS. Terms of agreement between the Department of Health, the HSE and the IMO regarding GP contractual reform and service development. Dublin: Health Services Executive (HSE), Department of Health; 2019.

Sheppard JP, Schwartz CL, Tucker KL, McManus RJ. Modern management and diagnosis of hypertension in the United Kingdom: home care and self-care. Ann Glob Health. 2016;82(2):274-87.